The Current and Future of Biomarkers of Immune Related Adverse Events
Bracamonte-Baran W, Kim S. The Current and Future of Biomarkers of Immune Related Adverse Events. Immunology And Allergy Clinics Of North America 2025, 45: 223-249. PMID: 40287170, DOI: 10.1016/j.iac.2025.01.010.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsImmune-related adverse eventsAdverse eventsMechanism of action of immune checkpoint inhibitorsImmune related adverse eventsAssociated with life-threateningRelated adverse eventsCheckpoint inhibitorsClinical responseReview biomarkersStratify riskLife-threateningCancer therapeuticsCancer
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply